# Requires health insurance policies to fully cover multi-marker testing related to certain patients

**Bill ID:** A6186
**Session:** 2024
**Sponsor:** Pamela J. Hunter
**Status:** In Assembly Committee
**PDF:** [A6186 PDF](https://legislation.nysenate.gov/pdf/bills/2024/A6186)

## Summary

Requires health insurance policies to fully cover multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  6186
 
  2023-2024 Regular Sessions
 
  I N  A S S E M B L Y
 
  April 3, 2023
  ___________
 
 Introduced by M. of A. HUNTER -- read once and referred to the Committee
  on Insurance
 
 AN  ACT  to  amend  the  insurance  law  and the social services law, in
  relation to requiring health insurance policies to fully cover  multi-
  marker  testing  related to ovarian cancer to patients which have been
  diagnosed with an ovarian adnexal mass

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
 amended by adding a new paragraph 11-c to read as follows:
  (11-C) (A) EVERY POLICY THAT PROVIDES COVERAGE FOR HOSPITAL,  SURGICAL
 OR  MEDICAL  CARE  SHALL  OFFER  FULL  COVERAGE FOR MULTI-MARKER TESTING
 RELATED TO OVARIAN CANCER TO PATIENTS WHICH HAVE BEEN DIAGNOSED WITH  AN
 OVARIAN ADNEXAL MASS.
  (B)  SUCH  ADDITIONAL  COVERAGE SHALL NOT BE SUBJECT TO ANNUAL DEDUCT-
 IBLES AND COINSURANCE BUT SHALL BE BORNE SOLELY BY THE INSURER.
  ยง 2. Subsection (l) of section 3221 of the insurance law is amended by
 adding a new paragraph 11-c to read as follows:
  (11-C) (A) EVERY INSURER DELIVERING A GROUP OR BLANKET POLICY OR ISSU-
 ING A GROUP OR BLANKET POLICY FOR DELIVERY IN THIS STATE  THAT  PROVIDES
 COVERAGE  FOR HOSPITAL, SURGICAL OR MEDICAL CARE SHALL OFFER FULL COVER-
 AGE FOR MULTI-MARKER TESTING RELATED TO OVARIAN CANCER TO PATIENTS WHICH
 HAVE BEEN DIAGNOSED WITH AN OVARIAN ADNEXAL MASS.
  (B) SUCH ADDITIONAL COVERAGE SHALL NOT BE SUBJECT  TO  ANNUAL  DEDUCT-
 IBLES AND COINSURANCE BUT SHALL BE BORNE SOLELY BY THE INSURER.
  ยง  3.  Section  4303  of  the insurance law is amended by adding a new
 subsection (p-1) to read as follows:
  (P-1) (1) A MEDICAL EXPENSE INDEMNITY CORPORATION, A HOSPITAL  SERVICE
 CORPORATION  OR  A HEALTH SERVICE CORPORATION THAT PROVIDES COVERAGE FOR
 HOSPITAL, SURGICAL OR MEDICAL CARE SHALL OFFER FULL COVERAGE FOR  MULTI-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD07245-01-3
 A. 6186  2
 
 MARKER  TESTING  RELATED  TO  OVARIAN CANCER TO PATIENTS WHICH HAVE BEEN
 DIAGNOSED WITH AN OVARIAN ADNEXAL MASS.
  (2)  SUCH  ADDITIONAL  COVERAGE SHALL NOT BE SUBJECT TO ANNUAL DEDUCT-
 IBLES AND COINSURANCE BUT SHALL BE BORNE SOLELY BY THE INSURER.
  ยง 4. Subdivision 2 of section 365-a of  the  social  services  law  is
 amended by adding a new paragraph (kk) to read as follows:
  (KK)  MULTI-MARKER TESTING RELATED TO OVARIAN CANCER TO PATIENTS WHICH
 HAVE BEEN DIAGNOSED WITH AN OVARIAN ADNEXAL MASS.
  ยง 5. This act shall take effect on the first of January next  succeed-
 ing  the  date  on  which  it shall have become a law and shall apply to
 policies issued, reissued, renewed, modified or amended on or after such
 date.